SEOM clinical guidelines for the adjuvant treatment of colorectal cancer

被引：0

作者：

Cristina Grávalos Castro

Joan Maurel Santasusana

Fernando Rivera Herrero

Ramón Salazar Soler

Isabel Sevilla García

Javier Sastre Valera

José M. Tabernero Caturla

Encarnación González Flores

María Lomas Garrido

Dolores Isla Casado

机构：

[1] 12 de Octubre University Hospital,Medical Oncology Department

[2] Hospital Clínic i Provincial,Servicio de Oncología Médica

[3] Hospital Universitario Marqués de Valdecilla,Servicio de Oncología Médica

[4] Hospital Durán i Reynals — Instituto Catalán de Oncología (ICO) L’Hospitalet de Llobregat,Servicio de Oncología Médica

[5] Hospital Clínico Universitario Virgen de la Victoria,Servicio de Oncología Médica

[6] Hospital Clínico Universitario San Carlos,Servicio de Oncología Médica

[7] Hospital General Universitario Vall d’Hebrón,Servicio de Oncología Médica

[8] Hospital Universitario Virgen de las Nieves,Servicio de Oncología Médica

[9] Hospital Médico Quirúrgico,Servicio de Oncología Médica

[10] Hospital Clínico Universitario Lozano Blesa,Servicio de Oncología Médica

[11] Hospital Universitario 12 de Octubre,Servicio de Oncología Médica

来源：

Clinical and Translational Oncology | 2010年 / 12卷

关键词：

Colorectal cancer; Diagnosis; Treatment; Guidelines; SEOM;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Colorectal cancer is the third most common malignant neoplasm and the second cause of death by cancer in western countries. In this manuscript, the clinical guidelines of the Spanish Society of Medical Oncology (SEOM) for diagnosis and adjuvant treatment of colon cancer and rectal cancer are reported.

引用

页码：724 / 728

页数：4

共 63 条

[1]

Greene F.L.(2002)A new TNM staging strategy for node-positive (stage III) colon cancer: an analysis of 50,042 patients Ann Surg 236 416-421

[2]

Stewart A.K.(2001)Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery Lancet 357 497-504

[3]

Norton H.J.(2005)Lymph node evaluation in colorectal cancer patients: a population-based study J Natl Cancer Inst 97 219-225

[4]

Beets-Tan R.G.(2009)Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. Colon Cancer Laparoscopic or Open Resection Study Group Lancet Oncol 10 44-52

[5]

Beets G.L.(2009)Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial J Clin Oncol 27 3109-3116

[6]

Vliegen R.F.(2008)A phase III trial comparing 5FULV to FULV+oxaliplatin in stage II or III carcinoma of the colon: survival results of NSABP Protocol C-07 J Clin Oncol 26 LBA4005-2064

[7]

Baxter N.N.(2006)Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06 J Clin Oncol 24 2059-2704

[8]

Virnig D.J.(2005)Capecitabine as adjuvant treatment for stage III colon cancer N Engl J Med 352 2696-3461

[9]

Rothenberger D.A.(2007)Irinotecan fluorouracil plus leucovorin is not superior to fluoruracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803 J Clin Oncol 25 3456-3125

[10]

Buunen M.(2009)Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3 J Clin Oncol 27 3117-3419

← 1 2 3 4 5 6 7 →